Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zidan Medical is a private U.S. medical device company developing a bronchoscopic radiofrequency ablation system for lung cancer treatment. Its lead product, the Zidan RF Ablation System, uses a very small flexible endobronchial catheter and a proprietary "virtual electrode" forward-throw design to deliver targeted, temperature-controlled energy to lung lesions. The company appears focused on minimally invasive ablation of peripheral lung tumors, positioning its technology as a tissue-sparing alternative to more invasive approaches. Public materials and publications indicate that Zidan has generated preclinical data and first-in-human feasibility data, suggesting an early clinical-stage medtech company rather than a traditional drug developer. The company is based in Cupertino, California and remains privately held.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zidan Medical.